FOLLOW US

Digital health trailblazer Omada Health Inc. ignited Wall Street’s pulse on Thursday after pricing its highly anticipated $150 million initial public offering, marking its entrance into the public market with a bold $1.1 billion valuation. Like a precision-cut scalpel, the deal sliced through market hesitations, falling neatly within its forecast range.

Represented by Latham & Watkins LLP, and with Davis Polk & Wardwell LLP counseling the underwriters, Omada floated 7.9 million shares at $19 each—the dead center of its projected $18 to $20 range. The stock will begin trading Friday on the Nasdaq under the ticker symbol OMDA, further injecting adrenaline into a suddenly revitalized IPO scene.

Digital Health Races Back Into Spotlight

Omada’s public debut isn’t happening in isolation. The company rides the wake of Circle Internet Group Inc.—a stablecoin issuer whose shares surged dramatically after its blockbuster $1.05 billion IPO earlier this week. The momentum signals that IPO windows, frozen for much of the past year, may finally be cracking open.

Omada’s entrance echoes the moves of peers like Hinge Health Inc., a physical therapy startup that recently raised $473 million, all while investors reorient toward scalable, tech-driven healthcare models.

Founded in San Francisco, Omada operates a virtual care platform designed to support patients between clinic visits. Through personalized digital interventions, the company helps users manage chronic conditions such as diabetes, hypertension, and musculoskeletal disorders. The system connects individuals with health coaches, physical therapists, and clinical specialists through a seamless virtual experience.

Explosive Growth Despite Lack of Profit

Omada’s trajectory has been steep. Its revenue climbed 38% year-over-year to $169.8 million, according to its SEC registration statement. Despite strong growth, the company remains unprofitable—a common trait among health tech firms leveraging massive upfront investments to capture long-term market share.

Its backers include venture titans U.S. Venture Partners, Andreessen Horowitz, and Revelation Partners. The company last raised capital in a $192 million Series E round in 2022.

Now, with over 2,000 enterprise clients—from boutique health plans to Fortune 500 behemoths—Omada is poised to leverage IPO proceeds to fuel expansion. Plans include working capital infusion, debt repayment, and potential acquisitions in a rapidly consolidating health tech market.

IPO Structure and Legal Teams

Underwriters, led by Morgan Stanley, Goldman Sachs, and J.P. Morgan, hold a 30-day option to purchase an additional 1.185 million shares, potentially raising total proceeds to $172.6 million.

Omada’s legal firepower includes Latham partners Kathleen Wells and Richard Kim, while underwriters rely on Davis Polk partners Alan Denenberg and Emily Roberts.

An Omada spokesperson declined to comment on the IPO Thursday.